Timothy C. Rodell - Concepedia

Author

Timothy C. Rodell

GlobeImmune (United States)

Also Known As

T C Rodell, T. C. Rodell, T. Rodell, T.C. Rodell, Timothy C Rodell, Timothy C. Rodell, Timothy Rodell

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

GlobeImmune (United States)University of Colorado Denver University of Colorado Health Gilead Sciences (United States)Vanderbilt University

About

Timothy C. Rodell is an author at GlobeImmune (United States) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	1.1K
2	Cell Biology	5	5	241
3	Allergy	2	2	74
4	Health Sciences	1	1	17
5	Social Sciences	1	1	209

Timothy C. Rodell

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Xanthine oxidase-derived hydrogen peroxide contributes to ischemia reperfusion-induced edema in gerbil brains. Antonia Patt, Alden H. Harken, Lisa K. Burton, Journal of Clinical Investigation Reperfusion-induced EdemaRedox BiologySocial SciencesOxidative StressCerebral Vascular Regulation	1988	209
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B Anna S. Lok, Calvin Q. Pan, Steven-Huy Han, Journal of Hepatology VaccinationVaccine DevelopmentViral HepatitisImmunologyHepatitis B	2016	172
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury Christopher R. Heery, B. Harpreet Singh, Myrna Rauckhorst, Cancer Immunology Research ImmunologyImmunoeditingPathologyImmunotherapyTumor Biology	2015	136
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis Carolina Boni, Harry L.A. Janssen, Marzia Rossi, Gastroenterology Viral PersistenceHepatologyHbv-specific T-cell ResponsesViral HepatitisChronic Hepatitis	2019	134
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease David M. Hockenbery, Scott Cruickshank, Timothy C. Rodell, Blood	2007	123
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins Aurelia A. Haller, Georg M. Lauer, Thomas H. King, Vaccine Adaptive Immune SystemT-regulatory CellImmunologyHcv Ns3Core Proteins	2006	105
Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study Anuj Gaggar, Claire Coeshott, David Apelian, Vaccine	2014	100
Xanthine oxidase mediates elastase-induced injury to isolated lungs and endothelium Timothy C. Rodell, John C. Cheronis, C. L. Ohnemus, Journal of Applied Physiology Acute Lung InjuryInflammatory Lung DiseaseLung InflammationLipid PeroxidationEdematous Lung Injury	1987	87
Mutation-Selective Tumor Remission with Ras-Targeted, Whole Yeast-Based Immunotherapy Yingnian Lu, Donald Bellgrau, Lori D. Dwyer‐Nield, Cancer Research	2004	73
A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral Clearance Thomas H. King, Charles B. Kemmler, Zhimin Guo, PLoS ONE	2014	69

Page 1